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Summary: The binding of bilirubin was analysed in the serum of a patient with unusual myeloma. This patient
presented an acquired Von Willebrand's disease due to the presence of a ternary complex formed by one
molecule of myeloma immunoglobulin G and two molecules of albumin (Harle et al. La Presse Medicale 79,
1661-1664(1990)).
The binding characteristics of bilirubin — number of sites (n) and association constants (k) — were estimated
in the serum of the proband, and compared with those of purified human serum albumin and pooled normal
human serum. The data suggest that complex formation between albumin and immunoglobulin induces
abnormal bilirubin binding in the patient's serum, which becomes apparent when the bilirubin/albumin ratio
exceeds 1.3. This abnormal binding may be due to conformational changes of the albumin molecule in the
complex. The greatly increased number of lower affinity binding sites for bilirubin is certainly due to the
abnormally high concentration of myeloma immunoglobulin G in the serum of the patient.
Introduction . , . . r , 4 . ,kj the average association constant for that class and
Human serum albumin is a macromolecule involved A the concentration of unbound ligand.
in binding and transport of low-molecular-mass com- Ώ. ,. Γ „ . , . -, . - . , Γ _, . . - , Binding properties of albumin are dependent on thepounds m blood plasma. The interaction of these . . Γ 4 Γ ' . r., 1 1 · ι jj K .;: j .,, „ . , integrity of the regions of the macromolecule involvedendogenous or exogenous ligands with albumin de- . .f · *· *A j· r ·^ , , *·· j- - j i_ ι in the association process. Many studies of interac-pends on the number of binding sites and the values 4. , 4 ,, . , „ . , , ,, . ' . , . . π. · ι ι tions between albumin a n d small molecules have beenof the related association constants. Theoretical anal- A , ,, .. . r i _ - j · · r i- , , . - . t , , , j , , reported, and localizations of binding sites for severalyses of binding have been developed by several au- , u . , .. , , , ° . ...., ,. ^ _° . , , , - . .... compounds have been published (see review (7)).thors (1 — 6); for independent classes of sites, equihb-
rium can be defined by the equation: In this report, we study the binding properties of
albumin in a patient with acquired Von IVillebrand's
— τ ni fcj A disease. Using electrophoresis, we earlier showed that
i -1 1 + ks A ' the serum of this patient does not contain free albu-
, min, but a complex of myeloma immunoglobulin G
kappa with albumin; this complex consists of one
r represents the moles of bound ligand per mol of molecule of immunoglobulin G linked to two mole-
macromolecule, cules of albumin by disulfide bridges (8). It seems
m the number of classes of binding sites, likely that the covalent bonding between the two
ni the number of sites in class i, species affects the spatial structure of the molecules
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Fig. I . A . Cellulose acetate electrophoresis of normal and patient sera. Electrophoresis was performed by applying 30 volts/cm
for 20 min in barbital buffer (20 mmol/1, pH 9.2), followed by staining with Ponceau solution.
B . Molecular mass determination on sodium dodecyl sulphate polyacrylamide gel. Tris glycine buffer (50 mmol/1, pH
8.6), sodium dodecyl sulphate 4%, polyacrylamide 4%. Current intensity 3.3 mA/tube for 60 min.
C . Cellulose acetate electrophoresis of the isolated complex and of patient serum. Conditions are the same as in figure
1A, except that barbital buffer was supplemented with 2-mercaptoethanol (10 ml/1) and samples were incubated 30 min
in buffer, at room temperature, before applying to the cellulose sheet.
and consequently the binding of ligands to albumin.
To investigate this possibility, we compared the bind-
ing equilibrium of bilirubin in the blood serum of this
patient with the binding data for albumin. The non-
bound bilirubin was determined by oxidation with
hydrogen peroxide and horseradish peroxidase1), as-
suming that the oxidation rate was greater than the
dissociation rate of the bilirubin-albumin complex (9,
10).
Materials and Methods
Albumin (3.3 mmol/1, Centre de Transfusion Sanguine de Mont-
pellier) was diluted to a concentration of 500 μηιοΐ/ΐ in 0.1
mol/1 phosphate buffer pH 7.4. Bilirubin was dissolved in iso-
tonic saline containing 0.1 mol/1 sodium hydroxide, then added
to the patient's serum or albumin solution. Total bilirubin was
measured by the Jendrassik-Michaelson-Bruckner method on an
Astra™ analytical system; albumin concentration was deter-
mined by the Doumas method (11); free bilirubin by the method
ofJacobsen & Wennberg (10), using horseradish peroxidase (EC
1.11.1.7). Because of the low solubility of bilirubin, and the
possibility of dimerization at neutral pH (12), or self-aggrega-
tion at high concentrations, we investigated molar total bili-
rubin/albumin ratios only up to a value of 2.5.
In this molar ratio range, and with the known affinity of
albumin for bilirubin, the molar ratio of bound bilirubin to
albumin and the molar ratio of total bilirubin to albumin are
very close. The intra-assay coefficients of variation are: ± 3%
for total bilirubin, ± 2% for albumin and ± 4% for free
bilirubin.
Case report
A 63 year-old male was admitted for repeated nose-bleeding to
the Centre Hospitalier de la Timone, Marseille, France. On
admittance, total serum proteins were 120 g/1; albumin was 600
μιηοΐ/ΐ; cellulose acetate electrophoresis revealed the absence of
albumin and the presence of an abnormal fraction in the oc2-
globulin region (fig. l A). An albumin-immunoglobulin G com-
plex was isolated on Sephacryl S-300 with a relative molecular
mass of 300000 (fig. IB); after reduction with 2-mercapto-
ethanol this complex dissociated into immunoglobulin G and
albumin (fig. 1C). After separation on a Sephadex G-100 col-
umn, we demonstrated that it was composed of one molecule
of immunoglobulin G (Afr 150000) and two molecules of al-
bumin (Mr 69 000) (8).
Results
Figure 2 shows that the molar ratio, total bilirubin/
albumin, plotted versus the values for free bilirubin
was a curve for albumin and nearly a straight line for
our patient's serum. For molar ratios approximately
< 1.3, the two curves are close, indicating a similar
partition of free and albumin-bound bilirubin, but
above this value the concentration, of free bilirubin
increases more rapidly in the presence of purified
albumin than in the presence of the patient's serum.
The binding values were calculated by using the fol-
lowing linear transformations;
') Enzyme: horseradish peroxidase (EC 1.11.1.7)
free bilirubin
molar ratio total bilirubin/albumin
= f (free bilirubin)
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and the reciprocal plot
free bilirubin
l
.molar ratio total bilirubin/albumE)·
to the experimental plot, but an even better graphical
fit was obtained with k, = 1 · 107 1/mol, and 17 as
the number of second-class sites (fig. 2).
two graphical representations giving a better estimate
for intercepts on the coordinate axes (6). The equa-
tions of curves are determined by computerized sec-
ond-order non-linear least-square curve fitting and
the intercepts are calculated. Based on the hypothesis
of two independent classes of binding sites, and using
the equations developed by Klotz & Hunston (4), we
determined the presence of two sites, with the asso-
ciation constants: kt = 3.8 · 107 1/mol and k2 = 1.2
• 107 1/mol for albumin. These values are in good
agreement with the results reported in previous work
(13 — 16). The computer-generated curve based on
these values was in close agreement with the experi-








Fig. 2. Binding isotherms for bilirubin at pH 7.4 and 25 °C.
Experimental curves: ο albumin; ^ our patient. Com-
puter generated curves using calculated binding quan-
tities: · simulation for albumin (nj = l, k* = 3.8
• ΙΟ71/mol, n2 = 1, k2 = 1.2 · 1071/mol); simula-
tion for our patient (ni = 1, k, = 1 · 1071/mol; n2 = 17,
k2 = 6.4 · 10s 1/mol).
It was assumed that the serum of our patient also
manifested two non-interacting classes of binding
sites. The total number of sites was obtained from the
inverse of the ordinate intercept of the reciprocal plot.
This value, 13.8, was rounded off to the nearest in-
teger, 14. The number of classes and association con-
stants were calculated with the same method as for
albumin. For the first class of sites, ki = 1.8 - 107
1/mol and the number of sites in this class was ni = 1;
the average value of the association constant for the
13 remaining sites was k2 = 6.4 · 1051/mol. The curve
generated by computer, using these values, was close
Discussion
Albumin is a monomeric protein whose complete
amino acid sequence (585 residues) is known (17). The
molecule possesses 17 disulphide bridges, a single cys-
teine residue in position 34 and a single tryptophanyl
residue in position 214. Brown et al. (18), on the basis
of a high degree of homology between bovine and
human albumin, proposed that human albumin was
formed by three similar globular domains I, II and
III. Each domain can be subdivided into two subdo-
mains (A and B) mainly structured as α-helices (19).
From hydrodynamic measurements performed on bo-
vine albumin, the molecule is depicted as an oblate
ellipsoid with axes 14 nm by 4 nm (20). Recent studies
of the three-dimensional structure of albumin (21)
reveal that domains are connected by non-helical seg-
ments, residues 177 to 200 between domains I and II,
and residues 369 to 392 between domains II and III.
For this reason, despite the high percentage of amino
acid residues involved in secondary structures (48%
α-helix and 15% -sheet (19)), albumin remains a
flexible molecule which undergoes reversible confor-
mational changes, particularly as a result of ligand-
binding; certain conformational changes exert coop-
erative or antagonist effects on ligand-binding (see
review (7)).
Albumin can bind one molecule of bilirubin with a
very high affinity and a second molecule with a lower
affinity. Jacobsen (22) suggests that residues 127 —
297 are involved in the first site, and that lysine residue
240 may be linked to one of the carboxylate groups
of bilirubin. At the same time, Berde et al. (23) re-
ported that the first site may be between domains I
and II. Broder sen et al. (24) have calculated, by flu-
orescence quenching, that the first bound bilirubin
molecule is located 2.2 nm from the tryptophan res-
idue; this distance is comparable with the value of
2.7 nm reported by Berde et al. (23). For the second
fixation-site, the results are conflicting. The observa-
tions of Gitzelmann et al. (25) suggest that the second
molecule of bilirubin is located in the region of amino
acids 446 — 547 (domain HI) at 2.4 nm from trypto-
phan 214. On the other hand, Brodersen et al. (24)
established that the second molecule of bilirubin is
closely bound with the first, at a distance of 1.8 nm
from tryptophan.
The different association constant and different num-
ber of binding sites for human serum albumin and
the serum of our patient clearly indicate that complex
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formation between albumin and immunoglobulin
modifies the binding isotherms of bilirubin (fig. 2).
The fact that all the albumin is linked (fig. 1A) and
that its primary structure is normal (indeed, the com-
plex with myeloma immunoglobulin appears in vivo
after plasmapheresis, as well as in vitro with normal
human albumin) indicates that the differences ob-
served reflect the resulting conformational changes of
bound albumin. The serum of our patient contains
one binding site with an affinity (k^ = 1 · 107 — 1.8
• 107 1/mol) intermediate between the two values de-
termined for albumin (k, = 3.8 · 107 1/mol, k2 = 1.2
• 1071/mol); our results also indicate that the second-
ary site is no longer operative, and that 13 to 17 sites
with 30-fold weaker affinity (k2 = 6.4 · 1051/mol) are
present. The linkage of albumin to immunoglobulin
by an S-S bond, probably derived from the sulphydryl
of cysteine 34 whose reactivity is distinctive at this
pH (20), can be expected to induce perturbations in
the intramolecular interactions of domain I, where
this cysteinyl residue is located. Although domain I
does not contribute to the binding mechanism of
bilirubin, our data suggest that one of the two high-
affinity sites is dramatically affected by the coupling
with immunoglobulin G.
Bilirubin can interact with other sites in serum such
as αϊ- and qc2-globulins (26, 27), but with one hundred
to one thousand-fold less binding strength than the
high-affinity site of albumin (27). It is clear that the
existence of 14 to 18 total binding sites, determined
in the serum of our patient, should not be attributed
solely to albumin but also to other plasma proteins.
Since the results obtained from healthy subjects do
not display such differences compared with pure al-
bumin solutions (data not shown), the results ob-
served are certainly due to the high concentration of
immunoglobulin G. In order to understand the per-
turbations induced, firstly by the association of al-
bumin with immunoglobulin G, and secondly, by the
abnormally high concentration of a protein other than
albumin, we plan to study the binding characteristics
of other ligands in the serum of our patient and of
other patients with hypergammaglobulinaemia.
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